Invasive Fusarium infections: A retrospective survey of 31 cases

Journal of Medical and Veterinary Mycology

Volumn 35, Issue 2, 1997, Pages 107-114

  Hennequin, C ^a   Lavarde, V ^b   Poirot, J L ^c   Rabodonirina, M ^d   Datry, A ^e   Aractingi, S ^f   Dupouy Camet, J ^g   Caillot, D ^h   Grange, F ⁱ   Kures, L ^j   Morin, O ^k   Lebeau, B ^l   Bretagne, S ^m   Guigen, C ⁿ   Basset, D ^o   Grillot, R ^l  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b HÔPITAL BROUSSAIS   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d UNIVERSITÉ LYON 1   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f HÔPITAL TENON   (France)

^g Université Paris Descartes   (France)

^h HÔPITAL DU BOCAGE   (France)

ⁱ INSTITUT GUSTAVE ROUSSY   (France)

^j UNIVERSITÉ DE LORRAINE   (France)

^k HÔTEL DIEU   (France)

^l UNIV GRENOBLE ALPES   (France)

^m HENRI MONDOR HOSPITAL   (France)

ⁿ Faculté de Médecine   (France)

^o Annexe Faculté de Médecine   (France)

more..

Author keywords

Fusarium; Invasive infections; Retrospective study

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; GENACONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ITRACONAZOLE; KETOCONAZOLE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FRANCE; FUSARIUM OXYSPORUM; FUSARIUM SOLANI; HUMAN; MALE; MORTALITY; MYCOSIS; PROGNOSIS;

FUSARIUM; FUSARIUM OXYSPORUM; FUSARIUM SOLANI;

EID: 79961242355     PISSN: 02681218     EISSN: None     Source Type: Journal    
DOI: 10.1080/02681219780000991     Document Type: Article

References (25)

1. Paya CV. Fungal infections in solid-organ transplantation. Clin Infect Dis 1993; 16: 677-88.
2. Morrison VA, Haake RJ, Weisdorf DJ. The spectrum of non-Candida fungal infections following bone marrow transplantation. Medicine 1993; 72: 78-89.
3. Anaissie E, Bodey GP, Kantarjian H, et al. New spectrum of fungal infections in patients with cancer. Rev Infect Dis 1989; 11: 369-78.
4. Guarro J, Gené J. Opportunistic fusarial infections in humans. Eur J Clin Microbiol Infect Dis 1995; 14: 741-54.
5. Martino P, Gastaldi R, Raccah R, Girmenia C. Clinical patterns of Fusarium infections in immunocompromised patients. J Infect 1994; 28 (Suppl. 1): 7-15.
6. Odds FC, Arai T, Disalvo AF, et al. Nomenclature of fungal diseases: a report and recommendations from a sub-committee of the International Society for Human and Animal Mycology (ISHAM). J Med Vet Mycol 1992; 30: 1-10.
7. Nelson PE, Dignani MC, Anaissie EJ. Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev 1994; 7: 479-504.
8. Anaissie E, Kantarjian H, Ro J, et al. The emerging role of Fusarium infections in patients with cancer. Medicine 1988; 67: 77-83.
9. Goldschmied-Reouven A, Friedman J, Block CS. Fusarium species isolated from non-ocular sites: a 10 year experience at an Israeli general hospital. J Mycol Med 1993; 3: 99-102.
10. Schneller FR, Gulati SC, Cunningham IB, et al. Fusarium infections in patients with hematologic malignancies. Leuk Res 1990; 14: 961-6.
11. Merz WG, Karp JE, Hoagland M, et al. Diagnosis and successful treatment of fusariosis in the compromised host. J Infect Dis 1988; 158: 1046-55.
12. Mowbray DN, Paller AS, Nelson PE, Kaplan RL. Disseminated Fusarium solani infection with cutaneous nodules in a bone marrow transplant patient. Int J Dermatol 1988; 27: 698-701.
13. Kwon-Chung KJ, Bennett JE. Infections due to miscellaneous moulds. Medical Mycology. Lea & Febiger, Philadelphia, 1992: 733-67.
14. Guarro J, Gené J. Fusarium infections. Criteria for the identification of the responsible species. Mycoses 1992; 35: 109-14.
15. Sekhon AS, Kaufman L, Moledina N, et al. An exoantigen test for the rapid identification of medically significant Fusarium species. J Med Vet Mycol 1995; 33: 287-9.
16. Reuben A, Anaissie E, Nelson PE, et al. Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method. Antimicrob Agents Chemother 1989; 33: 1647-9.
17. Van Cutsem JM. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. Chemotherapy (Basle) 1992; 38 (Suppl. 1): 3-11.
18. Anaissie E. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis 1992; 14 (Suppl. 1): S43-S53.
19. Viviani MA, Cofrancesco E, Boschetti C, Tortorano AM, Cortellaro M. Eradication of Fusarium infection in a leukopenic patient treated with liposomal amphotericin B. Mycoses 1991; 34: 255-6.
20. Engelhard D, Eldor A, Polacheck I, et al. Disseminated visceral fusariosis treated with amphotericin B phospholipid complex. Leuk Lymphoma 1993; 9: 358-92.
21. Patoux-Pibouin M, Couatarmanach A, Le Gall F, et al. Fusariose à Fusarium solani chez un adolescent leucémique. Ann Dermatol Véneréol 1992; 119: 377-80.
22. Roilides E, Pizzo PA. Modulation of host defenses by cytokines: evolving adjuncts in prevention and treatment of serious infections in immunocompromised hosts. Clin Infect Dis 1992; 15: 508-24.
23. Barrios NJ, Kirkpatrick DV, Murciano A, et al. Successful treatment of disseminated Fusarium infection in an immunocompromised child. Am J Pediatr Hematol Oncol 1990; 12: 319-24.
24. Viscoli C, Castagnola E, Moroni C, et al. Infection with Fusarium species in two children with neuroblastoma. Eur J Clin Microbiol Infect Dis 1990; 9: 773-6.
25. Spielberger RT, Falleroni MJ, Coene AJ, Larson RA. Concomitant amphotericin B therapy, granulocyte transfusions, and GM-CSF administration for disseminated infection with Fusarium in a granulocytopenic patient. Clin Infect Dis 1993; 16: 528-30.